Candriam Equities L Biotech.C EUR/ LU1120766388 /
| NAV2024-05-10 | Chg.-1.9100 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 215.7700EUR | -0.88% | reinvestment | Equity Worldwide | Candriam ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2015 | - | - | - | - | - | -0.99 | 5.05 | -12.19 | -11.06 | 8.94 | 8.18 | -2.47 | - |
| 2016 | -22.94 | -4.98 | -1.15 | 3.16 | 8.63 | -8.23 | 11.81 | -2.00 | 3.03 | -10.54 | 12.73 | -2.27 | -17.18% |
| 2017 | 2.97 | 8.66 | -0.57 | -0.74 | -6.02 | 7.82 | -0.95 | 5.93 | 1.46 | -5.24 | -2.17 | 0.73 | +11.22% |
| 2018 | 2.84 | -2.57 | -2.96 | -1.49 | 8.26 | 0.77 | 4.17 | 4.70 | -1.93 | -11.86 | 4.19 | -9.20 | -6.81% |
| 2019 | 12.70 | 4.36 | 0.82 | -4.77 | -3.93 | 7.06 | 0.91 | - | - | - | - | - | - |
| 2021 | - | - | - | - | - | - | 31.91 | 4.35 | -2.47 | 0.30 | -1.70 | 1.34 | - |
| 2022 | -9.30 | -1.76 | 7.03 | -2.16 | -5.45 | 6.05 | 7.35 | 2.94 | 0.68 | 5.55 | 1.91 | -6.30 | +4.91% |
| 2023 | 1.12 | -3.40 | -2.17 | 0.63 | 2.56 | -0.90 | -1.63 | 1.34 | -2.10 | -5.97 | 2.83 | 12.21 | +3.49% |
| 2024 | 3.19 | 1.72 | 0.15 | -5.32 | 2.20 | - | - | - | - | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 16.28% | 17.09% | 16.03% | 21.51% | 21.46% |
| Sharpe ratio | 0.07 | 2.07 | 0.13 | - | 0.25 |
| Best month | +12.21% | +12.21% | +12.21% | +12.21% | +31.91% |
| Worst month | -5.32% | -5.32% | -5.97% | -9.30% | -9.30% |
| Maximum loss | -9.57% | -9.57% | -14.01% | -19.84% | -19.84% |
| Outperformance | -3.05% | - | -1.13% | +0.44% | - |
All quotes in EUR
Tranches
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| Candriam Equities L Biotechnolog... | reinvestment | 2,007.9100 | +4.78% | +10.60% | |
| Candriam Equities L Biotech.C EU... | reinvestment | 215.7700 | +5.96% | - | |
| Candriam Equities L Biotech.I-H ... | reinvestment | 2,011.4900 | +2.45% | +2.84% | |
| Candriam Equities L Biotech.I EU... | reinvestment | 2,175.6599 | +6.72% | +24.55% | |
| Candriam Equities L Biotech.I GB... | reinvestment | 3,368.4399 | +5.60% | +23.32% | |
| Candriam Equities L Biotech.R GB... | reinvestment | 353.4500 | +5.84% | +27.22% | |
| Candriam Equities L Biotech.R EU... | reinvestment | 318.2700 | +6.94% | +27.11% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 196.1100 | +0.23% | +1.26% | |
| Candriam Equities L Biotech.V2 U... | reinvestment | 1,796.4301 | +5.18% | +13.37% | |
| Candriam Equities L Biotech.N-H ... | reinvestment | 145.6900 | - | - | |
| Candriam Equities L Biotech.N US... | reinvestment | 584.3600 | +3.62% | +8.40% | |
| Candriam Equities L Biotech.I US... | reinvestment | 5,493.3101 | +4.66% | +10.19% | |
| Candriam Equities L Biotech.C-H ... | reinvestment | 192.4400 | +1.80% | +2.42% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 200.6200 | +2.68% | +4.94% | |
| Candriam Equities L Biotech.R US... | reinvestment | 260.4000 | +4.91% | +12.52% | |
| Candriam Equities L Biotechnolo... | reinvestment | 820.1700 | +4.00% | +9.78% | |
| Candriam Equities L Biotechnolog... | paying dividend | 749.0600 | +3.97% | +9.68% |
Performance
| YTD | +1.73% | ||
|---|---|---|---|
| 6 Months | +17.81% | ||
| 1 Year | +5.96% | ||
| 3 Years | - | ||
| 5 Years | +55.61% | ||
| 10 Years | - | ||
| Since start | +43.85% | ||
| Year | |||
| 2023 | +3.49% | ||
| 2022 | +4.91% | ||
| 2018 | -6.81% | ||
| 2017 | +11.22% | ||
| 2016 | -17.18% | ||
